2023
Using micro-cognition biomarkers of neurosystem dysfunction to redefine ADHD subtypes: A scalable digital path to diagnosis based on brain function
Wexler B, Kish R. Using micro-cognition biomarkers of neurosystem dysfunction to redefine ADHD subtypes: A scalable digital path to diagnosis based on brain function. Psychiatry Research 2023, 326: 115348. PMID: 37494880, PMCID: PMC10517859, DOI: 10.1016/j.psychres.2023.115348.Peer-Reviewed Original ResearchConceptsPoor response inhibitionResponse inhibitionSymptom-based diagnosisGO/NOGO testMarked performance decrementsNew treatment developmentTD childrenADHD childrenADHD subtypesPerformance decrementsInconsistent attentionAbstract categoriesTreatment developmentNatural categoriesBrain functionADHDDifferent neuropathologiesChildren 6Individual patientsTreatment selection
2005
Cue-Induced Brain Activity Changes and Relapse in Cocaine-Dependent Patients
Kosten TR, Scanley BE, Tucker KA, Oliveto A, Prince C, Sinha R, Potenza MN, Skudlarski P, Wexler BE. Cue-Induced Brain Activity Changes and Relapse in Cocaine-Dependent Patients. Neuropsychopharmacology 2005, 31: 644-650. PMID: 16123763, DOI: 10.1038/sj.npp.1300851.Peer-Reviewed Original ResearchConceptsFunctional magnetic resonance imagingPosterior cingulate cortexCocaine-related cuesCocaine-dependent patientsBrain activationTreatment effectiveness scoreSensory association corticesBrain activity changesPCC activationCocaine cuesSuperior temporalBOLD activationCingulate cortexSubjective reportsTreatment developmentAssociation cortexCuesProcessing areasCocaine abusePhysiological activationCortexNonrelapsersBest predictorCocaine-free urinesDrug use